Philip J. Bergman, DVM, MS, PhD, DACVIM (Oncology)

Director, Clinical Studies
VCA
Katonah, NY, New York, United States

Dr. Bergman is the Director of Clinical Studies for VCA. He is an adjunct faculty member of the Memorial Sloan-Kettering Cancer Center. After finishing veterinary school from CSU in 1990, he was an intern at KSU, returned to CSU for his medical oncology residency and then completed a PhD Fellowship in human cancer biology from the M.D. Anderson Cancer Center in Houston. He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society.

Disclosure information not submitted.

Presentation(s):

• Current Oncology Literature: Changing How We Practice

  Wednesday, June 22, 2022
  2:00 PM – 3:00 PM CT

• Implementing Clinical Trials in Private Practice

  Thursday, June 23, 2022
  10:00 AM – 11:00 AM CT

• Current and Prospective Cancer Immunotherapies

  Thursday, June 23, 2022
  11:15 AM – 12:15 PM CT

• Clinical Integration of Tanovea and Laverdia for Canine Lymphoma

  Friday, June 24, 2022
  8:00 AM – 10:15 AM CT

• Compounding Pharmaceuticals in Veterinary Medicine

  Friday, June 24, 2022
  1:30 PM – 2:30 PM CT

• Implementing Clinical Trials in Private Practice (Interactive Session)

  Wednesday, September 21, 2022
  9:00 AM – 10:00 AM CT